Search Results 351-360 of 16271 for monoclonal antibody

  1. Head And Neck Cancers Clinical Trials - Mayo Clinic Research

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as durvalumab or cetuximab, may ...

  2. Living With Cancer: Ovarian cancer risk after hysterectomy - Mayo Clinic News Network

    Monoclonal antibody drugs use natural immune system functions to fight cancer. ... If you're considering monoclonal antibody therapy as part of your cancer ...

  3. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...

  4. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

  5. Macroglobulinemia Clinical Trials

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, can block ...

  6. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab, can block cancer growth ... ... antibody (ANCA)-associated vasculitis (AAV). LGX818 and MEK162 in Combination ...

  7. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. ... Monoclonal antibodies, such as ...

  8. Acute Myelogenous Leukemia Clinical Trials

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...

  9. Blistering Clinical Trials - Mayo Clinic Research

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  10. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... antibody), as measured from the last dose of bendamustine; relapsed ...